Global Hemophilia Gene Therapy Market Research Report 2025(Status and Outlook)
Hemophilia gene therapy represents a transformative therapeutic approach that involves the delivery of a functional copy of the gene responsible for producing clotting factors?typically factor VIII for hemophilia A or factor IX for hemophilia B?directly into a patient?s cells, most commonly via viral vectors such as adeno-associated viruses (AAVs), with the goal of enabling the body to produce its own stable and sustained levels of the missing clotting protein, thereby reducing or eliminating the need for regular prophylactic infusions and significantly decreasing the frequency of spontaneous bleeding episodes. This market is currently in a phase of rapid evolution, characterized by the recent regulatory approvals of pioneering products like etranacogene dezaparvovec (Hemgenix) for hemophilia B and valoctocogene roxaparvovec (Roctavian) for hemophilia A in various regions, which has catalyzed both commercial activity and further clinical development. Key drivers include the high unmet medical need among severe hemophilia patients, the potential for long-term cost savings despite high upfront treatment prices, and growing patient awareness and acceptance of gene-based interventions; however, the market also faces challenges such as safety concerns related to immune responses and vector-related toxicity, uncertainties around the durability of treatment effect, and significant pricing and reimbursement hurdles given the one-time cost often exceeding $1 million per patient. Geographically, North America and Europe are the leading markets due to advanced healthcare infrastructure, favorable regulatory pathways, and higher treatment adoption rates, while emerging markets are expected to gradually integrate these therapies as access improves and local clinical capabilities advance. Competition is intensifying among biotechnology and pharmaceutical companies, with several candidates in mid-to-late-stage clinical trials, and future growth is likely to be shaped by next-generation technologies aiming to improve efficacy, safety, and manufacturability, as well as the exploration of gene editing approaches such as CRISPR/Cas9 for more precise and durable genetic correction.
The global Hemophilia Gene Therapy market size was estimated at USD 1045.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 18.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hemophilia Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hemophilia Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hemophilia Gene Therapy market.
Global Hemophilia Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Spark Therapeutics
Ultragenyx
Shire PLC
Sangamo Therapeutics
Bioverativ
BioMarin
uniQure
Freeline Therapeutics
Market Segmentation (by Type)
Hemophilia A
Hemophilia B
Market Segmentation (by Application)
Hemophilia A Gene Therapy
Hemophilia B Gene Therapy
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hemophilia Gene Therapy Market
Overview of the regional outlook of the Hemophilia Gene Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hemophilia Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hemophilia Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Hemophilia Gene Therapy market size was estimated at USD 1045.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 18.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hemophilia Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hemophilia Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hemophilia Gene Therapy market.
Global Hemophilia Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Spark Therapeutics
Ultragenyx
Shire PLC
Sangamo Therapeutics
Bioverativ
BioMarin
uniQure
Freeline Therapeutics
Market Segmentation (by Type)
Hemophilia A
Hemophilia B
Market Segmentation (by Application)
Hemophilia A Gene Therapy
Hemophilia B Gene Therapy
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hemophilia Gene Therapy Market
Overview of the regional outlook of the Hemophilia Gene Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hemophilia Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hemophilia Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hemophilia Gene Therapy
1.2 Key Market Segments
1.2.1 Hemophilia Gene Therapy Segment by Type
1.2.2 Hemophilia Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEMOPHILIA GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hemophilia Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Hemophilia Gene Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEMOPHILIA GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hemophilia Gene Therapy Product Life Cycle
3.3 Global Hemophilia Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Hemophilia Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hemophilia Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hemophilia Gene Therapy Market Competitive Situation and Trends
3.8.1 Hemophilia Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hemophilia Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HEMOPHILIA GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Hemophilia Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEMOPHILIA GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hemophilia Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hemophilia Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 HEMOPHILIA GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hemophilia Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Hemophilia Gene Therapy Price by Type (2020-2025)
7 HEMOPHILIA GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hemophilia Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Hemophilia Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Hemophilia Gene Therapy Sales Growth Rate by Application (2020-2025)
8 HEMOPHILIA GENE THERAPY MARKET SALES BY REGION
8.1 Global Hemophilia Gene Therapy Sales by Region
8.1.1 Global Hemophilia Gene Therapy Sales by Region
8.1.2 Global Hemophilia Gene Therapy Sales Market Share by Region
8.2 Global Hemophilia Gene Therapy Market Size by Region
8.2.1 Global Hemophilia Gene Therapy Market Size by Region
8.2.2 Global Hemophilia Gene Therapy Market Size Market Share by Region
8.3 North America
8.3.1 North America Hemophilia Gene Therapy Sales by Country
8.3.2 North America Hemophilia Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hemophilia Gene Therapy Sales by Country
8.4.2 Europe Hemophilia Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hemophilia Gene Therapy Sales by Region
8.5.2 Asia Pacific Hemophilia Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hemophilia Gene Therapy Sales by Country
8.6.2 South America Hemophilia Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hemophilia Gene Therapy Sales by Region
8.7.2 Middle East and Africa Hemophilia Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HEMOPHILIA GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Hemophilia Gene Therapy by Region(2020-2025)
9.2 Global Hemophilia Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Hemophilia Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hemophilia Gene Therapy Production
9.4.1 North America Hemophilia Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Hemophilia Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hemophilia Gene Therapy Production
9.5.1 Europe Hemophilia Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Hemophilia Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hemophilia Gene Therapy Production (2020-2025)
9.6.1 Japan Hemophilia Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Hemophilia Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hemophilia Gene Therapy Production (2020-2025)
9.7.1 China Hemophilia Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Hemophilia Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Spark Therapeutics
10.1.1 Spark Therapeutics Basic Information
10.1.2 Spark Therapeutics Hemophilia Gene Therapy Product Overview
10.1.3 Spark Therapeutics Hemophilia Gene Therapy Product Market Performance
10.1.4 Spark Therapeutics Business Overview
10.1.5 Spark Therapeutics SWOT Analysis
10.1.6 Spark Therapeutics Recent Developments
10.2 Ultragenyx
10.2.1 Ultragenyx Basic Information
10.2.2 Ultragenyx Hemophilia Gene Therapy Product Overview
10.2.3 Ultragenyx Hemophilia Gene Therapy Product Market Performance
10.2.4 Ultragenyx Business Overview
10.2.5 Ultragenyx SWOT Analysis
10.2.6 Ultragenyx Recent Developments
10.3 Shire PLC
10.3.1 Shire PLC Basic Information
10.3.2 Shire PLC Hemophilia Gene Therapy Product Overview
10.3.3 Shire PLC Hemophilia Gene Therapy Product Market Performance
10.3.4 Shire PLC Business Overview
10.3.5 Shire PLC SWOT Analysis
10.3.6 Shire PLC Recent Developments
10.4 Sangamo Therapeutics
10.4.1 Sangamo Therapeutics Basic Information
10.4.2 Sangamo Therapeutics Hemophilia Gene Therapy Product Overview
10.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Product Market Performance
10.4.4 Sangamo Therapeutics Business Overview
10.4.5 Sangamo Therapeutics Recent Developments
10.5 Bioverativ
10.5.1 Bioverativ Basic Information
10.5.2 Bioverativ Hemophilia Gene Therapy Product Overview
10.5.3 Bioverativ Hemophilia Gene Therapy Product Market Performance
10.5.4 Bioverativ Business Overview
10.5.5 Bioverativ Recent Developments
10.6 BioMarin
10.6.1 BioMarin Basic Information
10.6.2 BioMarin Hemophilia Gene Therapy Product Overview
10.6.3 BioMarin Hemophilia Gene Therapy Product Market Performance
10.6.4 BioMarin Business Overview
10.6.5 BioMarin Recent Developments
10.7 uniQure
10.7.1 uniQure Basic Information
10.7.2 uniQure Hemophilia Gene Therapy Product Overview
10.7.3 uniQure Hemophilia Gene Therapy Product Market Performance
10.7.4 uniQure Business Overview
10.7.5 uniQure Recent Developments
10.8 Freeline Therapeutics
10.8.1 Freeline Therapeutics Basic Information
10.8.2 Freeline Therapeutics Hemophilia Gene Therapy Product Overview
10.8.3 Freeline Therapeutics Hemophilia Gene Therapy Product Market Performance
10.8.4 Freeline Therapeutics Business Overview
10.8.5 Freeline Therapeutics Recent Developments
11 HEMOPHILIA GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Hemophilia Gene Therapy Market Size Forecast
11.2 Global Hemophilia Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hemophilia Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Hemophilia Gene Therapy Market Size Forecast by Region
11.2.4 South America Hemophilia Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hemophilia Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Hemophilia Gene Therapy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Hemophilia Gene Therapy by Type (2026-2033)
12.1.2 Global Hemophilia Gene Therapy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Hemophilia Gene Therapy by Type (2026-2033)
12.2 Global Hemophilia Gene Therapy Market Forecast by Application (2026-2033)
12.2.1 Global Hemophilia Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Hemophilia Gene Therapy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hemophilia Gene Therapy
1.2 Key Market Segments
1.2.1 Hemophilia Gene Therapy Segment by Type
1.2.2 Hemophilia Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEMOPHILIA GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hemophilia Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Hemophilia Gene Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEMOPHILIA GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hemophilia Gene Therapy Product Life Cycle
3.3 Global Hemophilia Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Hemophilia Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hemophilia Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hemophilia Gene Therapy Market Competitive Situation and Trends
3.8.1 Hemophilia Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hemophilia Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HEMOPHILIA GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Hemophilia Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEMOPHILIA GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hemophilia Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hemophilia Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 HEMOPHILIA GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hemophilia Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Hemophilia Gene Therapy Price by Type (2020-2025)
7 HEMOPHILIA GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hemophilia Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Hemophilia Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Hemophilia Gene Therapy Sales Growth Rate by Application (2020-2025)
8 HEMOPHILIA GENE THERAPY MARKET SALES BY REGION
8.1 Global Hemophilia Gene Therapy Sales by Region
8.1.1 Global Hemophilia Gene Therapy Sales by Region
8.1.2 Global Hemophilia Gene Therapy Sales Market Share by Region
8.2 Global Hemophilia Gene Therapy Market Size by Region
8.2.1 Global Hemophilia Gene Therapy Market Size by Region
8.2.2 Global Hemophilia Gene Therapy Market Size Market Share by Region
8.3 North America
8.3.1 North America Hemophilia Gene Therapy Sales by Country
8.3.2 North America Hemophilia Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hemophilia Gene Therapy Sales by Country
8.4.2 Europe Hemophilia Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hemophilia Gene Therapy Sales by Region
8.5.2 Asia Pacific Hemophilia Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hemophilia Gene Therapy Sales by Country
8.6.2 South America Hemophilia Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hemophilia Gene Therapy Sales by Region
8.7.2 Middle East and Africa Hemophilia Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HEMOPHILIA GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Hemophilia Gene Therapy by Region(2020-2025)
9.2 Global Hemophilia Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Hemophilia Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hemophilia Gene Therapy Production
9.4.1 North America Hemophilia Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Hemophilia Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hemophilia Gene Therapy Production
9.5.1 Europe Hemophilia Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Hemophilia Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hemophilia Gene Therapy Production (2020-2025)
9.6.1 Japan Hemophilia Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Hemophilia Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hemophilia Gene Therapy Production (2020-2025)
9.7.1 China Hemophilia Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Hemophilia Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Spark Therapeutics
10.1.1 Spark Therapeutics Basic Information
10.1.2 Spark Therapeutics Hemophilia Gene Therapy Product Overview
10.1.3 Spark Therapeutics Hemophilia Gene Therapy Product Market Performance
10.1.4 Spark Therapeutics Business Overview
10.1.5 Spark Therapeutics SWOT Analysis
10.1.6 Spark Therapeutics Recent Developments
10.2 Ultragenyx
10.2.1 Ultragenyx Basic Information
10.2.2 Ultragenyx Hemophilia Gene Therapy Product Overview
10.2.3 Ultragenyx Hemophilia Gene Therapy Product Market Performance
10.2.4 Ultragenyx Business Overview
10.2.5 Ultragenyx SWOT Analysis
10.2.6 Ultragenyx Recent Developments
10.3 Shire PLC
10.3.1 Shire PLC Basic Information
10.3.2 Shire PLC Hemophilia Gene Therapy Product Overview
10.3.3 Shire PLC Hemophilia Gene Therapy Product Market Performance
10.3.4 Shire PLC Business Overview
10.3.5 Shire PLC SWOT Analysis
10.3.6 Shire PLC Recent Developments
10.4 Sangamo Therapeutics
10.4.1 Sangamo Therapeutics Basic Information
10.4.2 Sangamo Therapeutics Hemophilia Gene Therapy Product Overview
10.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Product Market Performance
10.4.4 Sangamo Therapeutics Business Overview
10.4.5 Sangamo Therapeutics Recent Developments
10.5 Bioverativ
10.5.1 Bioverativ Basic Information
10.5.2 Bioverativ Hemophilia Gene Therapy Product Overview
10.5.3 Bioverativ Hemophilia Gene Therapy Product Market Performance
10.5.4 Bioverativ Business Overview
10.5.5 Bioverativ Recent Developments
10.6 BioMarin
10.6.1 BioMarin Basic Information
10.6.2 BioMarin Hemophilia Gene Therapy Product Overview
10.6.3 BioMarin Hemophilia Gene Therapy Product Market Performance
10.6.4 BioMarin Business Overview
10.6.5 BioMarin Recent Developments
10.7 uniQure
10.7.1 uniQure Basic Information
10.7.2 uniQure Hemophilia Gene Therapy Product Overview
10.7.3 uniQure Hemophilia Gene Therapy Product Market Performance
10.7.4 uniQure Business Overview
10.7.5 uniQure Recent Developments
10.8 Freeline Therapeutics
10.8.1 Freeline Therapeutics Basic Information
10.8.2 Freeline Therapeutics Hemophilia Gene Therapy Product Overview
10.8.3 Freeline Therapeutics Hemophilia Gene Therapy Product Market Performance
10.8.4 Freeline Therapeutics Business Overview
10.8.5 Freeline Therapeutics Recent Developments
11 HEMOPHILIA GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Hemophilia Gene Therapy Market Size Forecast
11.2 Global Hemophilia Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hemophilia Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Hemophilia Gene Therapy Market Size Forecast by Region
11.2.4 South America Hemophilia Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hemophilia Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Hemophilia Gene Therapy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Hemophilia Gene Therapy by Type (2026-2033)
12.1.2 Global Hemophilia Gene Therapy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Hemophilia Gene Therapy by Type (2026-2033)
12.2 Global Hemophilia Gene Therapy Market Forecast by Application (2026-2033)
12.2.1 Global Hemophilia Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Hemophilia Gene Therapy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hemophilia Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Hemophilia Gene Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Hemophilia Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Hemophilia Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Hemophilia Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2024)
Table 10. Global Market Hemophilia Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Hemophilia Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Hemophilia Gene Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Hemophilia Gene Therapy Sales by Type (K Units)
Table 26. Global Hemophilia Gene Therapy Market Size by Type (M USD)
Table 27. Global Hemophilia Gene Therapy Sales (K Units) by Type (2020-2025)
Table 28. Global Hemophilia Gene Therapy Sales Market Share by Type (2020-2025)
Table 29. Global Hemophilia Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Hemophilia Gene Therapy Market Size Share by Type (2020-2025)
Table 31. Global Hemophilia Gene Therapy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Hemophilia Gene Therapy Sales (K Units) by Application
Table 33. Global Hemophilia Gene Therapy Market Size by Application
Table 34. Global Hemophilia Gene Therapy Sales by Application (2020-2025) & (K Units)
Table 35. Global Hemophilia Gene Therapy Sales Market Share by Application (2020-2025)
Table 36. Global Hemophilia Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Hemophilia Gene Therapy Market Share by Application (2020-2025)
Table 38. Global Hemophilia Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Hemophilia Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 40. Global Hemophilia Gene Therapy Sales Market Share by Region (2020-2025)
Table 41. Global Hemophilia Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Table 43. North America Hemophilia Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 44. North America Hemophilia Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Hemophilia Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Hemophilia Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Hemophilia Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Hemophilia Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Hemophilia Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 50. South America Hemophilia Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Hemophilia Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Hemophilia Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Hemophilia Gene Therapy Production (K Units) by Region(2020-2025)
Table 54. Global Hemophilia Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Hemophilia Gene Therapy Revenue Market Share by Region (2020-2025)
Table 56. Global Hemophilia Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Hemophilia Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Hemophilia Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Hemophilia Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Hemophilia Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Spark Therapeutics Basic Information
Table 62. Spark Therapeutics Hemophilia Gene Therapy Product Overview
Table 63. Spark Therapeutics Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Spark Therapeutics Business Overview
Table 65. Spark Therapeutics SWOT Analysis
Table 66. Spark Therapeutics Recent Developments
Table 67. Ultragenyx Basic Information
Table 68. Ultragenyx Hemophilia Gene Therapy Product Overview
Table 69. Ultragenyx Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Ultragenyx Business Overview
Table 71. Ultragenyx SWOT Analysis
Table 72. Ultragenyx Recent Developments
Table 73. Shire PLC Basic Information
Table 74. Shire PLC Hemophilia Gene Therapy Product Overview
Table 75. Shire PLC Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Shire PLC Business Overview
Table 77. Shire PLC SWOT Analysis
Table 78. Shire PLC Recent Developments
Table 79. Sangamo Therapeutics Basic Information
Table 80. Sangamo Therapeutics Hemophilia Gene Therapy Product Overview
Table 81. Sangamo Therapeutics Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Sangamo Therapeutics Business Overview
Table 83. Sangamo Therapeutics Recent Developments
Table 84. Bioverativ Basic Information
Table 85. Bioverativ Hemophilia Gene Therapy Product Overview
Table 86. Bioverativ Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Bioverativ Business Overview
Table 88. Bioverativ Recent Developments
Table 89. BioMarin Basic Information
Table 90. BioMarin Hemophilia Gene Therapy Product Overview
Table 91. BioMarin Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. BioMarin Business Overview
Table 93. BioMarin Recent Developments
Table 94. uniQure Basic Information
Table 95. uniQure Hemophilia Gene Therapy Product Overview
Table 96. uniQure Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. uniQure Business Overview
Table 98. uniQure Recent Developments
Table 99. Freeline Therapeutics Basic Information
Table 100. Freeline Therapeutics Hemophilia Gene Therapy Product Overview
Table 101. Freeline Therapeutics Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Freeline Therapeutics Business Overview
Table 103. Freeline Therapeutics Recent Developments
Table 104. Global Hemophilia Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 105. Global Hemophilia Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 106. North America Hemophilia Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 107. North America Hemophilia Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 108. Europe Hemophilia Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 109. Europe Hemophilia Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 110. Asia Pacific Hemophilia Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 111. Asia Pacific Hemophilia Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 112. South America Hemophilia Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 113. South America Hemophilia Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 114. Middle East and Africa Hemophilia Gene Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 115. Middle East and Africa Hemophilia Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 116. Global Hemophilia Gene Therapy Sales Forecast by Type (2026-2033) & (K Units)
Table 117. Global Hemophilia Gene Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 118. Global Hemophilia Gene Therapy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 119. Global Hemophilia Gene Therapy Sales (K Units) Forecast by Application (2026-2033)
Table 120. Global Hemophilia Gene Therapy Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hemophilia Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Hemophilia Gene Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Hemophilia Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Hemophilia Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Hemophilia Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2024)
Table 10. Global Market Hemophilia Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Hemophilia Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Hemophilia Gene Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Hemophilia Gene Therapy Sales by Type (K Units)
Table 26. Global Hemophilia Gene Therapy Market Size by Type (M USD)
Table 27. Global Hemophilia Gene Therapy Sales (K Units) by Type (2020-2025)
Table 28. Global Hemophilia Gene Therapy Sales Market Share by Type (2020-2025)
Table 29. Global Hemophilia Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Hemophilia Gene Therapy Market Size Share by Type (2020-2025)
Table 31. Global Hemophilia Gene Therapy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Hemophilia Gene Therapy Sales (K Units) by Application
Table 33. Global Hemophilia Gene Therapy Market Size by Application
Table 34. Global Hemophilia Gene Therapy Sales by Application (2020-2025) & (K Units)
Table 35. Global Hemophilia Gene Therapy Sales Market Share by Application (2020-2025)
Table 36. Global Hemophilia Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Hemophilia Gene Therapy Market Share by Application (2020-2025)
Table 38. Global Hemophilia Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Hemophilia Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 40. Global Hemophilia Gene Therapy Sales Market Share by Region (2020-2025)
Table 41. Global Hemophilia Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Table 43. North America Hemophilia Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 44. North America Hemophilia Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Hemophilia Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Hemophilia Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Hemophilia Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Hemophilia Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Hemophilia Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 50. South America Hemophilia Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Hemophilia Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Hemophilia Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Hemophilia Gene Therapy Production (K Units) by Region(2020-2025)
Table 54. Global Hemophilia Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Hemophilia Gene Therapy Revenue Market Share by Region (2020-2025)
Table 56. Global Hemophilia Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Hemophilia Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Hemophilia Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Hemophilia Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Hemophilia Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Spark Therapeutics Basic Information
Table 62. Spark Therapeutics Hemophilia Gene Therapy Product Overview
Table 63. Spark Therapeutics Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Spark Therapeutics Business Overview
Table 65. Spark Therapeutics SWOT Analysis
Table 66. Spark Therapeutics Recent Developments
Table 67. Ultragenyx Basic Information
Table 68. Ultragenyx Hemophilia Gene Therapy Product Overview
Table 69. Ultragenyx Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Ultragenyx Business Overview
Table 71. Ultragenyx SWOT Analysis
Table 72. Ultragenyx Recent Developments
Table 73. Shire PLC Basic Information
Table 74. Shire PLC Hemophilia Gene Therapy Product Overview
Table 75. Shire PLC Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Shire PLC Business Overview
Table 77. Shire PLC SWOT Analysis
Table 78. Shire PLC Recent Developments
Table 79. Sangamo Therapeutics Basic Information
Table 80. Sangamo Therapeutics Hemophilia Gene Therapy Product Overview
Table 81. Sangamo Therapeutics Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Sangamo Therapeutics Business Overview
Table 83. Sangamo Therapeutics Recent Developments
Table 84. Bioverativ Basic Information
Table 85. Bioverativ Hemophilia Gene Therapy Product Overview
Table 86. Bioverativ Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Bioverativ Business Overview
Table 88. Bioverativ Recent Developments
Table 89. BioMarin Basic Information
Table 90. BioMarin Hemophilia Gene Therapy Product Overview
Table 91. BioMarin Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. BioMarin Business Overview
Table 93. BioMarin Recent Developments
Table 94. uniQure Basic Information
Table 95. uniQure Hemophilia Gene Therapy Product Overview
Table 96. uniQure Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. uniQure Business Overview
Table 98. uniQure Recent Developments
Table 99. Freeline Therapeutics Basic Information
Table 100. Freeline Therapeutics Hemophilia Gene Therapy Product Overview
Table 101. Freeline Therapeutics Hemophilia Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Freeline Therapeutics Business Overview
Table 103. Freeline Therapeutics Recent Developments
Table 104. Global Hemophilia Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 105. Global Hemophilia Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 106. North America Hemophilia Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 107. North America Hemophilia Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 108. Europe Hemophilia Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 109. Europe Hemophilia Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 110. Asia Pacific Hemophilia Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 111. Asia Pacific Hemophilia Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 112. South America Hemophilia Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 113. South America Hemophilia Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 114. Middle East and Africa Hemophilia Gene Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 115. Middle East and Africa Hemophilia Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 116. Global Hemophilia Gene Therapy Sales Forecast by Type (2026-2033) & (K Units)
Table 117. Global Hemophilia Gene Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 118. Global Hemophilia Gene Therapy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 119. Global Hemophilia Gene Therapy Sales (K Units) Forecast by Application (2026-2033)
Table 120. Global Hemophilia Gene Therapy Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hemophilia Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hemophilia Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Hemophilia Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Hemophilia Gene Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hemophilia Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hemophilia Gene Therapy Product Life Cycle
Figure 13. Hemophilia Gene Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Hemophilia Gene Therapy Revenue Share by Manufacturers in 2024
Figure 15. Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Hemophilia Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hemophilia Gene Therapy Revenue in 2024
Figure 18. Industry Chain Map of Hemophilia Gene Therapy
Figure 19. Global Hemophilia Gene Therapy Market PEST Analysis
Figure 20. Global Hemophilia Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hemophilia Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Hemophilia Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Hemophilia Gene Therapy by Type in 2024
Figure 29. Market Size Share of Hemophilia Gene Therapy by Type (2020-2025)
Figure 30. Market Size Share of Hemophilia Gene Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hemophilia Gene Therapy Market Share by Application
Figure 33. Global Hemophilia Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Hemophilia Gene Therapy Sales Market Share by Application in 2024
Figure 35. Global Hemophilia Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Hemophilia Gene Therapy Market Share by Application in 2024
Figure 37. Global Hemophilia Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hemophilia Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Hemophilia Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hemophilia Gene Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hemophilia Gene Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Hemophilia Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hemophilia Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hemophilia Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Hemophilia Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hemophilia Gene Therapy Market Size Market Share by Country in 2024
Figure 55. Germany Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hemophilia Gene Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Hemophilia Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hemophilia Gene Therapy Market Size Market Share by Region in 2024
Figure 68. China Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hemophilia Gene Therapy Sales and Growth Rate (K Units)
Figure 79. South America Hemophilia Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Hemophilia Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Hemophilia Gene Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hemophilia Gene Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Hemophilia Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hemophilia Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hemophilia Gene Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hemophilia Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Hemophilia Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Hemophilia Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Hemophilia Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Hemophilia Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Hemophilia Gene Therapy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Hemophilia Gene Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Hemophilia Gene Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Hemophilia Gene Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Hemophilia Gene Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global Hemophilia Gene Therapy Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Hemophilia Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hemophilia Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Hemophilia Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Hemophilia Gene Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hemophilia Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hemophilia Gene Therapy Product Life Cycle
Figure 13. Hemophilia Gene Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Hemophilia Gene Therapy Revenue Share by Manufacturers in 2024
Figure 15. Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Hemophilia Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hemophilia Gene Therapy Revenue in 2024
Figure 18. Industry Chain Map of Hemophilia Gene Therapy
Figure 19. Global Hemophilia Gene Therapy Market PEST Analysis
Figure 20. Global Hemophilia Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hemophilia Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Hemophilia Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Hemophilia Gene Therapy by Type in 2024
Figure 29. Market Size Share of Hemophilia Gene Therapy by Type (2020-2025)
Figure 30. Market Size Share of Hemophilia Gene Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hemophilia Gene Therapy Market Share by Application
Figure 33. Global Hemophilia Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Hemophilia Gene Therapy Sales Market Share by Application in 2024
Figure 35. Global Hemophilia Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Hemophilia Gene Therapy Market Share by Application in 2024
Figure 37. Global Hemophilia Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hemophilia Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Hemophilia Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hemophilia Gene Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hemophilia Gene Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Hemophilia Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hemophilia Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hemophilia Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Hemophilia Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hemophilia Gene Therapy Market Size Market Share by Country in 2024
Figure 55. Germany Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hemophilia Gene Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Hemophilia Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hemophilia Gene Therapy Market Size Market Share by Region in 2024
Figure 68. China Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hemophilia Gene Therapy Sales and Growth Rate (K Units)
Figure 79. South America Hemophilia Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Hemophilia Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Hemophilia Gene Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hemophilia Gene Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Hemophilia Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hemophilia Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hemophilia Gene Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hemophilia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Hemophilia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hemophilia Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Hemophilia Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Hemophilia Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Hemophilia Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Hemophilia Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Hemophilia Gene Therapy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Hemophilia Gene Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Hemophilia Gene Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Hemophilia Gene Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Hemophilia Gene Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global Hemophilia Gene Therapy Market Share Forecast by Application (2026-2033)
